CP

No. of samples analysed

No. of samples below lower limit of specification(low failures)

No. of samples above upper limit of specification(high failures)

No. of samples within limit of specification (passes)

CQT

CQS

SPT

CQT

CQS

SPT

CQT

CQS

SPT

CQT

CQS

SPT

A

D

A

A

D

A

D

A

A

D

A

D

A

A

D

TH

1

1

1

0

0

0

0

1

0

0

0

0

0

1

1

1

1

0

DH

1

-

1

0

0

-

0

1

0

0

-

0

0

1

1

-

1

0

MS

2

1

2

0

1

1

0

1

0

0

0

0

0

2

1

0

2

1

HC

1

1

1

0

0

0

0

1

0

0

0

0

0

1

1

1

1

0

P

3

2

3

0

0

0

0

3

0

0

1

0

0

3

3

1

3

0

VS

7

7

7

0

0

0

0

5

0

0

1

0

0

7

7

6

7

2

H

5

4

5

1

ns

0

0

ns

1

ns

1

0

ns

3

ns

3

5

ns

NK

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total

20

16

20

1

1

1

0

12

1

0

3

0

0

18

14

12

20

3

CP: Collection point

CQT: Chloroquine tablets

CQS: Chloroquine syrup

SPT: Sulphadoxine/pyrimethamine tablets

A: Content of active ingredient

D: Dissolution rate

TH: Teaching hospital

DH: District hospital

MS: Medical stores

HC: Health centre

P: Pharmacy

VS: Vendor/shop

H: Household

NK: Not known

ns: Sample not sufficient